NAVELBINE Trademark

Trademark Overview

On Friday, November 28, 1986, a trademark application was filed for NAVELBINE with the United States Patent and Trademark Office. The USPTO has given the NAVELBINE trademark a serial number of 73632692. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, June 23, 2017. This trademark is owned by PIERRE FABRE MEDICAMENT. The NAVELBINE trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICALS, NAMELY, AN ANTI-CANCER PREPARATION
navelbine

General Information

Serial Number73632692
Word MarkNAVELBINE
Filing DateFriday, November 28, 1986
Status800 - REGISTERED AND RENEWED
Status DateFriday, June 23, 2017
Registration Number1452870
Registration DateTuesday, August 18, 1987
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 26, 1987

Trademark Statements

Goods and ServicesPHARMACEUTICALS, NAMELY, AN ANTI-CANCER PREPARATION

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 7, 1987
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePIERRE FABRE MEDICAMENT
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
Address92100 BOULOGNE
FR
Party NamePIERRE FABRE MEDICAMENT
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressPARIS
FR
Party NamePIERRE FABRE MEDICAMENT
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressPARIS
FR

Trademark Events

Event DateEvent Description
Friday, June 23, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, June 23, 2017REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Friday, June 23, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, June 22, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 27, 2017TEAS SECTION 8 & 9 RECEIVED
Thursday, August 18, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, June 9, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 7, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 7, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 7, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 7, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 17, 2007REVIEW OF CORRESPONDENCE COMPLETE
Wednesday, August 8, 2007ASSIGNED TO PARALEGAL
Wednesday, July 11, 2007REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Saturday, August 4, 2007REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, August 4, 2007REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, August 4, 2007REGISTERED - SEC. 15 ACKNOWLEDGED
Saturday, August 4, 2007ASSIGNED TO PARALEGAL
Wednesday, July 11, 2007REGISTERED - SEC. 15 AFFIDAVIT FILED
Wednesday, July 11, 2007REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Wednesday, July 11, 2007PAPER RECEIVED
Monday, March 19, 2007CASE FILE IN TICRS
Sunday, October 2, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 20, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 14, 1993REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, May 24, 1993REGISTERED - SEC. 8 (6-YR) FILED
Tuesday, August 18, 1987REGISTERED-PRINCIPAL REGISTER
Tuesday, May 26, 1987PUBLISHED FOR OPPOSITION
Saturday, April 25, 1987NOTICE OF PUBLICATION
Wednesday, March 25, 1987APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 9, 1987CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 12, 1987NON-FINAL ACTION MAILED
Thursday, February 5, 1987ASSIGNED TO EXAMINER

Related Keywords

navelbine preparation cancer anti namely pharmaceuticals